CoChat

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo

Open access
Yao, K, Gietema, J A, Shida, S, Selvakumaran, M, Fonrose, X, Haas, N B, Testa, J, O'Dwyer, P J · 2005 · British Journal of Cancer

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Hypoxia is an important selective force in the clonal evolution of tumours. Through HIF-1 and other transcription factors combined with tumour-specific genetic alterations, hypoxia is a dominant factor in the angiogenic phenotype. Cellular adaptation to hypoxia is an important requirement of tumour progression independent of angiogenesis. The adaptive changes, insofar as they alter hypoxia-induced apoptosis, are likely to determine responsiveness to antiangiogenic strategies. To investigate this adaptation of tumour cells to hypoxia, we recreated in vitro the in vivo situation of chronic intermittent exposure to low-oxygen levels. The colon carcinoma cell lines HT29 and HCT116 were subjected to 40 episodes of sublethal hypoxia (4 h) three times a week. The resulting two hypoxia-conditioned cell lines have been maintained in culture for more than 2 years. In both cell lines changes in doubling times occurred: in HT29 an increase, and in HCT116 a decrease. Cell survival in response to hypoxia and to DNA damage differed strikingly in the two cell lines. The HT29 hypoxia-conditioned cells were more resistant than the parental line to a 24 h hypoxic challenge, while those from HCT116 surprisingly were more sensitive. Sensitivity to cisplatin in vitro was also significantly different for the hypoxia-conditioned compared with the parental lines, suggesting a change in pathways leading to apoptosis following DNA damage signaling. The growth of both conditioned cell lines in vivo as xenografts in immunodeficient (SCID) mice was more rapid than their parental lines, and was accompanied in each by evidence of enhanced vascular proliferation as a consequence of the hypoxia-conditioning. Thus the changes in apoptotic susceptibility were independent of altered angiogenesis. The derivation of these lines provides a model for events within hypoxic regions of colon cancers, and for the acquisition of resistance and sensitivity characteristics that may have therapeutic implications for the use of antiangiogenesis drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602864

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Survival of conditioned cells following various periods of hypoxia, as measured by the MTT assay. Cells were exposed to hypoxia for 4 h three times weekly, for up to 40 exposures (corresponding to HP10 to HP40 and HCP10 to HCP40), and cells harvested and stored after every 10 hypoxic treatments. For analysis of survival in hypoxia, cells were plated in 96-well plates, exposed to profound hypoxia for the durations indicated, and cultured under oxic conditions for an additional 72 h.
Figure 1 Survival of conditioned cells following various periods of hypoxia, as measured by the MTT assay. Cells were exposed to hypoxia for 4 h three times weekly, for up to 40 exposures (corresponding to HP10 to HP40 and HCP10 to HCP40), and cells harvested and stored after every 10 hypoxic treatments. For analysis of survival in hypoxia, cells were plated in 96-well plates, exposed to profound hypoxia for the durations indicated, and cultured under oxic conditions for an additional 72 h.CC BY · PubMed Central
Figure 2 Sensitivity of hypoxia-conditioned cell lines to cisplatin as measured by the MTT assay. Cells were plated in 96-well plates, and after 18–24 h to allow adherence, a range of concentrations of cisplatin was added. For hypoxic incubation, the plates were immediately placed in the anaerobic chamber, left for 24 h at 37°C, and returned to an oxic environment for an additional 48 h. The MTT assay was performed at 72 h after initial exposure to the drugs in all cells. The one asterisk denotes the statistically significant difference between hypoxia-conditioned cell lines and its parental cell line with P-value <0.05.
Figure 2 Sensitivity of hypoxia-conditioned cell lines to cisplatin as measured by the MTT assay. Cells were plated in 96-well plates, and after 18–24 h to allow adherence, a range of concentrations of cisplatin was added. For hypoxic incubation, the plates were immediately placed in the anaerobic chamber, left for 24 h at 37°C, and returned to an oxic environment for an additional 48 h. The MTT assay was performed at 72 h after initial exposure to the drugs in all cells. The one asterisk denotes the statistically significant difference between hypoxia-conditioned cell lines and its parental cell line with P-value <0.05.CC BY · PubMed Central
Figure 3 Tumour growth curve of HT29, HP40 (A), and HCT116, HCP40 (B) in SCID mice. tumours were generated by subcutaneous injection of 107 cells in the left flank, and bidimensional measurements made every three days. The curves shown are the combined results of two separate experiments, the results of which were comparable.
Figure 3 Tumour growth curve of HT29, HP40 (A), and HCT116, HCP40 (B) in SCID mice. tumours were generated by subcutaneous injection of 107 cells in the left flank, and bidimensional measurements made every three days. The curves shown are the combined results of two separate experiments, the results of which were comparable.CC BY · PubMed Central
Figure 4 (A) Northern blot of RNA from the cell lines indicated, under oxic or hypoxic (16 h) conditions, probed with human VEGF and HIF-1α cDNAs. (B) Immunohistochemistry of formalin-fixed, paraffin-embedded tumour sections following 7 days' tumour growth of HT29, HP40, HCT116 and HCP40 implanted subcutaneously in scid mice. Sections of tumour were incubated with rat anti-mouse CD31, and developed by an immunoperoxidase technique.
Figure 4 (A) Northern blot of RNA from the cell lines indicated, under oxic or hypoxic (16 h) conditions, probed with human VEGF and HIF-1α cDNAs. (B) Immunohistochemistry of formalin-fixed, paraffin-embedded tumour sections following 7 days' tumour growth of HT29, HP40, HCT116 and HCP40 implanted subcutaneously in scid mice. Sections of tumour were incubated with rat anti-mouse CD31, and developed by an immunoperoxidase technique.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 82

Metadata

Authors
Yao, K., Gietema, J. A., Shida, S., Selvakumaran, M., Fonrose, X., Haas, N. B., Testa, J., & O'Dwyer, P. J.
Affiliations
  • University of Pennsylvania (US)
  • University Medical Center Groningen (NL)
  • Fox Chase Cancer Center (US)
Corresponding author
O'Dwyer, P J
Venue
British Journal of Cancer
Published
2005-12
Volume
93
Issue
12
Pages
1356-1363
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W1970274697
Cited by
82
References
58
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 13 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 4 · 2013: 3 · 2012: 1
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-sa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-sa)
Funders
  • U.S. Department of Health and Human Services
  • National Institutes of Health
  • National Cancer Institute (R01CA049820, CA-49820)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
hypoxia, colon cancer, HCT116 cells, HT-29 cells, apoptosis, HIF-1, angiogenesis, xenograft tumor growth, cisplatin resistance, DNA damage response, cell proliferation, anti-angiogenic therapy
MeSH terms
Adaptation, Physiological, Animals, Cell Survival, Colonic Neoplasms, DNA Damage, Female, Humans, Immunohistochemistry, Neovascularization, Pathologic, Transplantation, Heterologous, Tumor Cells, Cultured, Cell Hypoxia, Mice, SCID, Apoptosis, Drug Resistance, Neoplasm, In Situ Nick-End Labeling, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.